Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqing Chen

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Scientific Reports|July 16, 2020
CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatmentZhao Fu, Ningning Tang, Yanqing Chen, et al.
Plant Communications|December 18, 2024
Cropformer: An interpretable deep learning framework for crop genomic predictionHao Wang, Shen Yan, Wenxi Wang, et al.
Virulence|May 23, 2026
Effects of fecal microbiota transplantation and probiotics on the gut microbiome in antibiotic-treated septic patients: A pilot randomized controlled trialYuanzhuo Chen, Jian Zhao, Jiangman Zhao, et al.
The Journal of Investigative Dermatology|June 27, 2024
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2Andrew Blauvelt, Kenneth B Gordon, Richard G Langley, et al.
Molecular Plant|April 16, 2026
Green Revolution-associated DELLA accumulation enhances salt tolerance in cereals by disrupting INDETERMINATE SPIKELET1 biomolecular condensatesXiliu Cheng, Haoran Wang, Mingjie Lyu, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 8, 2024
Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 SubstudyAndrew Blauvelt, Richard G Langley, Patrick J Branigan, et al.
Emerging Microbes & Infections|June 24, 2018
Landscape of the genome and host cell response of Mycobacterium shigaense reveals pathogenic featuresHaiqin Jiang, Jiya Sun, Yanqing Chen, et al.
Clinical Pharmacology and Therapeutics|October 27, 2017
Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic PredictorsXuejiao Hu, Mei Zhang, Hao Bai, et al.
Acta Dermato-Venereologica|November 19, 2025
Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world StudyYajie Yu, Yanqing Chen, Yuping Zhang, et al.
JID Innovations : Skin Science From Molecules to Population Health|September 3, 2024
Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE SubstudyAndrew Blauvelt, Yanqing Chen, Patrick J Branigan, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Scientific Reports|July 16, 2020
CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatmentZhao Fu, Ningning Tang, Yanqing Chen, et al.
Plant Communications|December 18, 2024
Cropformer: An interpretable deep learning framework for crop genomic predictionHao Wang, Shen Yan, Wenxi Wang, et al.
Virulence|May 23, 2026
Effects of fecal microbiota transplantation and probiotics on the gut microbiome in antibiotic-treated septic patients: A pilot randomized controlled trialYuanzhuo Chen, Jian Zhao, Jiangman Zhao, et al.
The Journal of Investigative Dermatology|June 27, 2024
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2Andrew Blauvelt, Kenneth B Gordon, Richard G Langley, et al.
Molecular Plant|April 16, 2026
Green Revolution-associated DELLA accumulation enhances salt tolerance in cereals by disrupting INDETERMINATE SPIKELET1 biomolecular condensatesXiliu Cheng, Haoran Wang, Mingjie Lyu, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 8, 2024
Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 SubstudyAndrew Blauvelt, Richard G Langley, Patrick J Branigan, et al.
Emerging Microbes & Infections|June 24, 2018
Landscape of the genome and host cell response of Mycobacterium shigaense reveals pathogenic featuresHaiqin Jiang, Jiya Sun, Yanqing Chen, et al.
Clinical Pharmacology and Therapeutics|October 27, 2017
Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic PredictorsXuejiao Hu, Mei Zhang, Hao Bai, et al.
Acta Dermato-Venereologica|November 19, 2025
Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world StudyYajie Yu, Yanqing Chen, Yuping Zhang, et al.
JID Innovations : Skin Science From Molecules to Population Health|September 3, 2024
Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE SubstudyAndrew Blauvelt, Yanqing Chen, Patrick J Branigan, et al.
Pageof 15